Dentist, Rasht, Gilan, Iran.
Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
BMC Oral Health. 2023 Dec 19;23(1):1014. doi: 10.1186/s12903-023-03682-9.
Recurrent aphthous stomatitis has a complex and inflammatory origin. Among the great variety of medications it is increasingly common to use herbal medicines due to the adverse side effects of chemical medications. Considering the anti-inflammatory properties of cinnamaldehyde and the lack of studies related to the effectiveness of its nano form; This study investigates the effect of cinnamaldehyde and nano cinnamaldehyde on the healing rate of recurrent aphthous stomatitis lesions.
In a laboratory experiment, cinnamaldehyde was converted into niosomal nanoparticles. The niosome vesicles diameter and polydispersity index were measured at 25°C using a dynamic light scattering (DLS) Mastersizer 2000 (Malvern Panalytical technologies: UK) and Zetasizer Nano ZS system (Malvern Instruments Worcestershire: UK). After characterizing these particles, the (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) [XTT] assay was used to assess the toxicity of cinnamaldehyde and nano cinnamaldehyde on gingival fibroblast (HGF) and macrophage (THP-1) cells. By determining the release of TNF-α, IL-6, and TGF-β cytokines using ELISA kits, the level of tissue repair and anti-inflammatory capabilities of these two substances were evaluated.
The size and loading rate of the cinnamaldehyde nanoparticles were established after its creation. The optimized nanovesicle exhibited the following characteristics: particle size of 228.75 ± 2.38 nm, PDI of 0.244 ± 0.01, the zeta potential of -10.87 ± 1.09 mV and the drug encapsulation percentage of 66.72 ± 3.93%. PDIs range was between 0.242-0.274. The zeta potential values at 25°C were from -2.67 to -12.9 mV. The results of the XTT test demonstrated that nano cinnamaldehyde exhibited dose-dependent toxicity effects. Moreover, nano cinnamaldehyde released more TGF-β and had better reparative effects when taken at lower concentrations than cinnamaldehyde.
Nano cinnamaldehyde and cinnamaldehyde are effective in repairing tissue when used in non-toxic amounts. After confirmation in animal models, it is envisaged that these substances can be utilized to treat recurrent aphthous stomatitis.
复发性阿弗他口炎具有复杂的炎症起源。由于化学药物的不良反应,越来越多的人开始使用草药药物,其中有各种各样的药物。考虑到肉桂醛的抗炎特性以及缺乏有关其纳米形式有效性的研究;本研究调查了肉桂醛和纳米肉桂醛对复发性阿弗他口炎病变愈合率的影响。
在实验室实验中,将肉桂醛转化为非离子囊泡纳米颗粒。使用动态光散射(DLS)Mastersizer 2000(Malvern Panalytical technologies:英国)和 Zetasizer Nano ZS 系统(Malvern Instruments Worcestershire:英国)在 25°C 下测量非离子囊泡的粒径和多分散指数。对这些颗粒进行表征后,使用(2,3-双-(2-甲氧基-4-硝基-5-磺苯基)-2H-四唑-5-羧基苯胺)[XTT]测定法评估肉桂醛和纳米肉桂醛对牙龈成纤维细胞(HGF)和巨噬细胞(THP-1)细胞的毒性。通过使用 ELISA 试剂盒测定 TNF-α、IL-6 和 TGF-β 细胞因子的释放,评估了这两种物质的组织修复和抗炎能力。
肉桂醛纳米颗粒创建后确定了其大小和载药量。优化的纳米囊泡具有以下特征:粒径为 228.75±2.38nm,PDI 为 0.244±0.01,zeta 电位为-10.87±1.09mV,药物包封率为 66.72±3.93%。PDI 范围在 0.242-0.274 之间。在 25°C 时,zeta 电位值在-2.67 至-12.9 mV 之间。XTT 试验的结果表明,纳米肉桂醛具有剂量依赖性的毒性作用。此外,纳米肉桂醛释放出更多的 TGF-β,并且在较低浓度下比肉桂醛具有更好的修复作用。
在使用非毒性剂量时,纳米肉桂醛和肉桂醛均可有效修复组织。在动物模型中得到证实后,预计这些物质可用于治疗复发性阿弗他口炎。